60 Days
Source:
سواليف
First Locally Produced Pneumococcal Vaccine Registration
The Jordanian Food and Drug Administration has announced the registration of the first locally produced vaccine against pneumococcus, which is the TQ-PCV VAX 13-valent Pneumococcal Polysaccharide Conjugate Vaccine. This vaccine is manufactured in collaboration with the Chinese company Wolfax for the benefit of Al-Taqaddum Pharmaceuticals in Jordan. The vaccine aims to protect children aged three months to five years from infectious diseases caused by 13 strains of Streptococcus pneumoniae by boosting their immunity. This achievement represents an important step in the development of the national pharmaceutical industry and enhances Jordan's position as a regional hub for innovation and pharmaceutical industries. Additionally, it supports pharmaceutical security and ensures the availability of high-quality medicines for citizens.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)